Dengue Therapeutic Pipeline Review 2015

1
Dengue Pipeline Review, H1 2015 By RnRMarketRese
arch

• Browse more reports on Pharmaceuticals at
  http//www.rnrmarketresearch.com/reports/life-scie
  nces/pharmaceuticals

http//www.rnrmarketresearch.com/
sales_at_RnRMarketResearch.com 1 888 391 5441
2
Dengue Pipeline Review, H1 2015

• Global Markets Directs, Dengue Pipeline
  Review, H1 2015', provides an overview of the
  Dengues therapeutic pipeline.
• Dengue fever is a disease caused by a family of
  viruses that are transmitted by mosquitoes. It
  can affect anyone but tends to be more severe in
  people with compromised immune systems. Dengue is
  known by other name dandy fever". The Symptoms
  of dengue fever is usually headache, fever,
  severe muscle aches, and petechial rash and has a
  history of being in an area where dengue fever is
  endemic. Rest and fluid intake for hydration is
  important for the Dengue patient.
• Complete report available at http//www.rnrmarketr
  esearch.com/dengue-pipeline-review-h1-2015-market-
  report.html .

http//www.rnrmarketresearch.com/
sales_at_RnRMarketResearch.com 1 888 391 5441
3
Dengue Pipeline Review, H1 2015

• This report provides comprehensive information on
  the therapeutic development for Dengue, complete
  with comparative analysis at various stages,
  therapeutics assessment by drug target, mechanism
  of action (MoA), route of administration (RoA)
  and molecule type, along with latest updates, and
  featured news and press releases. It also reviews
  key players involved in the therapeutic
  development for Dengue and special features on
  late-stage and discontinued projects.
•  
• Note Certain sections in the report may be
  removed or altered based on the availability and
  relevance of data for the indicated disease.

http//www.rnrmarketresearch.com/
sales_at_RnRMarketResearch.com 1 888 391 5441
4
Dengue Pipeline Review, H1 2015

• Scope
• The report provides a snapshot of the global
  therapeutic landscape of Dengue.
• The report reviews key pipeline products under
  drug profile section which includes, product
  description, MoA and RD brief, licensing and
  collaboration details other developmental
  activities.
• The report reviews key players involved in the
  therapeutics development for Dengue and enlists
  all their major and minor projects.
• The report summarizes all the dormant and
  discontinued pipeline projects.

http//www.rnrmarketresearch.com/
sales_at_RnRMarketResearch.com 1 888 391 5441
5
Dengue Pipeline Review, H1 2015

• Reasons to Buy
• Provides strategically significant competitor
  information, analysis, and insights to formulate
  effective RD development strategies.
• Identify emerging players with potentially strong
  product portfolio and create effective
  counter-strategies to gain competitive advantage.
• Develop strategic initiatives by understanding
  the focus areas of leading companies.
• Identify and understand important and diverse
  types of therapeutics under development for
  Dengue.

http//www.rnrmarketresearch.com/
sales_at_RnRMarketResearch.com 1 888 391 5441
6
Dengue Pipeline Review, H1 2015

• For more details contact Mr. Ritesh Tiwari
  sales_at_rnrmarketresearch.com / 18883915441

RnRMarkertResearch RnRMarketResearch.com, an
online repository of market  research reports,
offers in-depth analysis of over 5000 market
segments. RnR Market Research library has
syndicated reports by leading market research 
publishers across the globe.

http//www.rnrmarketresearch.com/
sales_at_RnRMarketResearch.com 1 888 391 5441